Development and Validation of a Nomogram for Predicting Mortality in Patients with Atrial Fibrillation and Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention in a Chinese Multicenter Cohort

Background. This study is aimed at to establish an effective prognostic nomogram for patients with atrial fibrillation (AF) and acute coronary syndrome (ACS) underwent percutaneous coronary intervention (PCI). Methods. The nomogram was based on a retrospective study of 977 patients with AF and ACS w...

Full description

Saved in:
Bibliographic Details
Main Authors: Can Hua, Haitao Tian, Yubin Wang, Jianyong Zheng, Pengfei Liu, Boyang Zhang, Nannan Wang, Haihong Tang, Feng Wang, Xiufeng Xie, Haifeng Yuan, Tianchang Li
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Applied Bionics and Biomechanics
Online Access:http://dx.doi.org/10.1155/2022/2586400
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550783215730688
author Can Hua
Haitao Tian
Yubin Wang
Jianyong Zheng
Pengfei Liu
Boyang Zhang
Nannan Wang
Haihong Tang
Feng Wang
Xiufeng Xie
Haifeng Yuan
Tianchang Li
author_facet Can Hua
Haitao Tian
Yubin Wang
Jianyong Zheng
Pengfei Liu
Boyang Zhang
Nannan Wang
Haihong Tang
Feng Wang
Xiufeng Xie
Haifeng Yuan
Tianchang Li
author_sort Can Hua
collection DOAJ
description Background. This study is aimed at to establish an effective prognostic nomogram for patients with atrial fibrillation (AF) and acute coronary syndrome (ACS) underwent percutaneous coronary intervention (PCI). Methods. The nomogram was based on a retrospective study of 977 patients with AF and ACS who underwent PCI who were admitted to any of the 11 tertiary hospitals in the Beijing area between 2009 and 2015. The predictive accuracy and discriminative ability of the nomogram were determined by a concordance index (C-index) and calibration curve and were compared using current risk scores such as GRACE, CRUSADE, CHA2DS2-VASc, and HAS-BLED. The results were validated using bootstrap resampling and a retrospective cohort study of 409 patients enrolled in Fuwai Hospital at the same institution. Results. Independent factors derived from multivariable analysis of the primary cohort to predict all-cause mortality were age, pattern of ACS, red blood cell distribution width, N-terminal proBNP, and serum creatinine, all of which were assembled into the nomogram. The calibration curve for the probability of recurrence showed that the nomogram-based predictions were in good agreement with actual observations. The C-index of the nomogram for predicting mortality was 0.764 (95% CI, 0.718-0.810), which was statistically higher than the C-index values for the current risk scores (from 0.573 to 0.681). In the validation cohort, the C-index of the nomogram for predicting all-cause death was 0.706 (95% CI 0.601-0.811), with no significant differences compared with GRACE and CRUSADE, but better than that of CHA2DS2-VASc and HAS-BLED. Conclusions. The nomogram has good prognostic prediction for patients with AF and ACS who underwent PCI.
format Article
id doaj-art-22db33e41868432e993e44c55bbf19aa
institution Kabale University
issn 1754-2103
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Applied Bionics and Biomechanics
spelling doaj-art-22db33e41868432e993e44c55bbf19aa2025-02-03T06:05:50ZengWileyApplied Bionics and Biomechanics1754-21032022-01-01202210.1155/2022/2586400Development and Validation of a Nomogram for Predicting Mortality in Patients with Atrial Fibrillation and Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention in a Chinese Multicenter CohortCan Hua0Haitao Tian1Yubin Wang2Jianyong Zheng3Pengfei Liu4Boyang Zhang5Nannan Wang6Haihong Tang7Feng Wang8Xiufeng Xie9Haifeng Yuan10Tianchang Li11The Second School of Clinical MedicineDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyThe Second School of Clinical MedicineDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyThe Second School of Clinical MedicineThe Second School of Clinical MedicineThe Second School of Clinical MedicineBackground. This study is aimed at to establish an effective prognostic nomogram for patients with atrial fibrillation (AF) and acute coronary syndrome (ACS) underwent percutaneous coronary intervention (PCI). Methods. The nomogram was based on a retrospective study of 977 patients with AF and ACS who underwent PCI who were admitted to any of the 11 tertiary hospitals in the Beijing area between 2009 and 2015. The predictive accuracy and discriminative ability of the nomogram were determined by a concordance index (C-index) and calibration curve and were compared using current risk scores such as GRACE, CRUSADE, CHA2DS2-VASc, and HAS-BLED. The results were validated using bootstrap resampling and a retrospective cohort study of 409 patients enrolled in Fuwai Hospital at the same institution. Results. Independent factors derived from multivariable analysis of the primary cohort to predict all-cause mortality were age, pattern of ACS, red blood cell distribution width, N-terminal proBNP, and serum creatinine, all of which were assembled into the nomogram. The calibration curve for the probability of recurrence showed that the nomogram-based predictions were in good agreement with actual observations. The C-index of the nomogram for predicting mortality was 0.764 (95% CI, 0.718-0.810), which was statistically higher than the C-index values for the current risk scores (from 0.573 to 0.681). In the validation cohort, the C-index of the nomogram for predicting all-cause death was 0.706 (95% CI 0.601-0.811), with no significant differences compared with GRACE and CRUSADE, but better than that of CHA2DS2-VASc and HAS-BLED. Conclusions. The nomogram has good prognostic prediction for patients with AF and ACS who underwent PCI.http://dx.doi.org/10.1155/2022/2586400
spellingShingle Can Hua
Haitao Tian
Yubin Wang
Jianyong Zheng
Pengfei Liu
Boyang Zhang
Nannan Wang
Haihong Tang
Feng Wang
Xiufeng Xie
Haifeng Yuan
Tianchang Li
Development and Validation of a Nomogram for Predicting Mortality in Patients with Atrial Fibrillation and Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention in a Chinese Multicenter Cohort
Applied Bionics and Biomechanics
title Development and Validation of a Nomogram for Predicting Mortality in Patients with Atrial Fibrillation and Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention in a Chinese Multicenter Cohort
title_full Development and Validation of a Nomogram for Predicting Mortality in Patients with Atrial Fibrillation and Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention in a Chinese Multicenter Cohort
title_fullStr Development and Validation of a Nomogram for Predicting Mortality in Patients with Atrial Fibrillation and Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention in a Chinese Multicenter Cohort
title_full_unstemmed Development and Validation of a Nomogram for Predicting Mortality in Patients with Atrial Fibrillation and Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention in a Chinese Multicenter Cohort
title_short Development and Validation of a Nomogram for Predicting Mortality in Patients with Atrial Fibrillation and Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention in a Chinese Multicenter Cohort
title_sort development and validation of a nomogram for predicting mortality in patients with atrial fibrillation and acute coronary syndrome who underwent percutaneous coronary intervention in a chinese multicenter cohort
url http://dx.doi.org/10.1155/2022/2586400
work_keys_str_mv AT canhua developmentandvalidationofanomogramforpredictingmortalityinpatientswithatrialfibrillationandacutecoronarysyndromewhounderwentpercutaneouscoronaryinterventioninachinesemulticentercohort
AT haitaotian developmentandvalidationofanomogramforpredictingmortalityinpatientswithatrialfibrillationandacutecoronarysyndromewhounderwentpercutaneouscoronaryinterventioninachinesemulticentercohort
AT yubinwang developmentandvalidationofanomogramforpredictingmortalityinpatientswithatrialfibrillationandacutecoronarysyndromewhounderwentpercutaneouscoronaryinterventioninachinesemulticentercohort
AT jianyongzheng developmentandvalidationofanomogramforpredictingmortalityinpatientswithatrialfibrillationandacutecoronarysyndromewhounderwentpercutaneouscoronaryinterventioninachinesemulticentercohort
AT pengfeiliu developmentandvalidationofanomogramforpredictingmortalityinpatientswithatrialfibrillationandacutecoronarysyndromewhounderwentpercutaneouscoronaryinterventioninachinesemulticentercohort
AT boyangzhang developmentandvalidationofanomogramforpredictingmortalityinpatientswithatrialfibrillationandacutecoronarysyndromewhounderwentpercutaneouscoronaryinterventioninachinesemulticentercohort
AT nannanwang developmentandvalidationofanomogramforpredictingmortalityinpatientswithatrialfibrillationandacutecoronarysyndromewhounderwentpercutaneouscoronaryinterventioninachinesemulticentercohort
AT haihongtang developmentandvalidationofanomogramforpredictingmortalityinpatientswithatrialfibrillationandacutecoronarysyndromewhounderwentpercutaneouscoronaryinterventioninachinesemulticentercohort
AT fengwang developmentandvalidationofanomogramforpredictingmortalityinpatientswithatrialfibrillationandacutecoronarysyndromewhounderwentpercutaneouscoronaryinterventioninachinesemulticentercohort
AT xiufengxie developmentandvalidationofanomogramforpredictingmortalityinpatientswithatrialfibrillationandacutecoronarysyndromewhounderwentpercutaneouscoronaryinterventioninachinesemulticentercohort
AT haifengyuan developmentandvalidationofanomogramforpredictingmortalityinpatientswithatrialfibrillationandacutecoronarysyndromewhounderwentpercutaneouscoronaryinterventioninachinesemulticentercohort
AT tianchangli developmentandvalidationofanomogramforpredictingmortalityinpatientswithatrialfibrillationandacutecoronarysyndromewhounderwentpercutaneouscoronaryinterventioninachinesemulticentercohort